AVTAR S DHILLON Insider Trading $ARTH Arch Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AVTAR S DHILLON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AVTAR S DHILLON. AVTAR S DHILLON is Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and President & CEO in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in Vitality Biopharma, Inc. ($STVF) and Director in ONCOSEC MEDICAL Inc ($ONCS.D) and Director in Nemus Bioscience, Inc. ($NMUS) and Director in Arch Therapeutics, Inc. ($ARTH).
AVTAR S DHILLON in Arch Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of AVTAR S DHILLON: Director
Holdings: 8,517,373 shares
Current Value: $5,791,814
Latest Transaction: Jul 20 2018
$ARTH Market Capitalization: $92.55M
$ARTH Previous Close: $0.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of AVTAR S DHILLON in Arch Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARTH, GEB, ONCS, NMUS, VBIO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.43 | 220,000 | 93,500 | 220,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 220,000 | 0 | 8,517,373 | 8.3 M to 8.5 M (+2.65 %) |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.65 | 400,000 | 260,000 | 400,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 400,000 | 0 | 8,297,373 | 7.9 M to 8.3 M (+5.06 %) |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.39 | 830,000 | 323,700 | 830,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 737,000 | 0 | 7,897,373 | 7.2 M to 7.9 M (+10.29 %) |
| Aug 19 2015 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.28 | 355,000 | 99,400 | 355,000 |
Page: 1